CLEARPOINT NEURO INC. - COMMON STOCK

ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022

26 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Mini Conference

29 Mar 2022 16:01:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results

01 Mar 2022 16:08:12 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue

15 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference

05 Jan 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System

17 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Third Quarter 2021 Results

09 Nov 2021 16:05:03 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients

08 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference

04 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors

02 Nov 2021 16:05:03 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021

26 Oct 2021 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Second Quarter 2021 Results

10 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor medical AG

09 Aug 2021 08:00:01 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® Neuro Navigation System at Hôpital Fondation Rothschild in Paris

04 Aug 2021 16:05:02 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Second Quarter 2021 Results August 10, 2021

02 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution

21 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

15 Jul 2021 16:30:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland

16 Jun 2021 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Set to Join Russell 3000® Index

14 Jun 2021 09:15:00 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease

08 Jun 2021 07:30:00 By Nasdaq GlobeNewswire